Perfusion Imaging Market is anticipated to reach US$ 8.3 Billion by 2032 | FMI Study

321 pages of text The market for perfusion imaging is expected to grow from US$ 2.1 billion in 2022 to US$ 8.3 billion by 2032 as a result of the prevalence of neurological and cardiovascular diseases in the world.

According to FMI, during the forecast period from 2022 to 2032, the perfusion imaging market is expected to demonstrate the aforementioned growth at a CAGR of 6.8%.

Perfusion imagining helps in identifying nutritive blood supply to an element of tissue. Perfusion imaging techniques have the capability to generate both perfusion measurements and perfusion maps of the region of interest. In the perfusion imaging market, the application of such imaging techniques have been growing over the years. The market growth is primarily due to need for perfusion imaging for evaluating key body functions via assessing a number of functional and metabolic parameters.

Request a Sample Report with Table of Content (ToC) @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9650

The various perfusion imaging tools available in the market ranges from microspheres to computed tomography. These product tools help in mapping the blood through the brain’s vascular network. The market of perfusion imaging is expected to have a healthy CAGR over the forecast period due to continuous product lunch and demand for novel techniques to non-invasively measure various hemodynamic parameters.

Perfusion Imaging: Market Dynamics

The perfusion imaging market is anticipated to increase in the forecast period. It is anticipated that the growing demand for non-invasive therapies and treatment will drive the market of perfusion imaging in the forecast period. Rise in number of cardiovascular diseases, brain tumours, tumour-related angiogenesis etc. is also expected to drive the market of perfusion imaging market.

According to WHO, globally one billion people every year suffer from either one or many type of neurological disorders. Amongst these 50 million account for epilepsy and allied diseases where as 24 million suffer from Alzheimer. Prolonged sickness in neurological disorders results in 6.8 million death.  However, fast processing of perfusion imaging systems and tools which takes 60-75 seconds of time to image the circulation of blood supply helps in patient’s treatment process immensely.

Other recent developments in perfusion imaging market include new radioactive material with shorter life span. It reduces exposure of the patient to radioactive material. However high treatment cost, expensive devices and poor hi-tech healthcare penetration in lower income regions will restraint the growth of the perfusion imaging market.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9650

Perfusion Imaging Market: Overview

Measurement of tissue perfusion imaging primarily depends on the performance and concentration of tracer agent in the target organ of interest. Nowadays, new and exogenous tracers are being used in Perfusion Imaging which are equally effective with lesser side effects. These include chilled saline solution, radio nucleotides and iodinated radiographic contrast material. With recent developments in MR imaging, both exogenous and endogenous tracer agents have been extensively used in the perfusion imaging market

Perfusion Imaging Market: Region-wise Outlook

North America will account for the largest share in global perfusion imaging market. Presence of manufacturing site of some of the key perfusion imaging product manufacturers is expected to generate regions revenue. European regions owing to aggressive healthcare infrastructure will also be leading revenue generating market after North America for perfusion imaging. East and South Asian countries along with some of the Latin American countries are expected to be the fastest growing perfusion imaging market in the forecast period due to these regions advancements in healthcare facilities and rise in annual per capita income.

GCC countries from Middle East and African region are also expected to show decent growth but some poor countries from region will negatively impact the global perfusion imaging market growth. It is believed lack of training sessions for operating the systems is the main reason for region’s poor market growth for perfusion imaging.

Grow your profit margin with Future Market Insights – Buy the report@ https://www.futuremarketinsights.com/checkout/9650

Perfusion Imaging Market: Key Players

Some of the key players operating in global perfusion imaging market are GE Healthcare, Toshiba Medical System., Positron, Aetna Inc, NeuSoft, Bracco, Cigna, kmhlabs, Perimed AB., Siemens Health, Philips Healthcare, Lantheus Medical Cardiac Imaging Solutions Inc. and others.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs